drugset / Trial / NCT06676423
Evaluate the Safety of Neuronata-R® Inj. Suspended With HypoTHermosol® FRS (HTS-FRS) in Patients With ALS
NaSingle-groupOpen-labelTreatment
Summary
This clinical trial is a single-center, open-label, and phase I clinical trial to Evaluate the Safety of Neuronata-R® Inj. suspended with HypoTHermosol® FRS (HTS-FRS) in Patients with Amyotrophic Lateral Sclerosis.
Timeline
- Start
- 2022-11-09
- Primary completion
- 2023-11-27
- Completion
- 2023-11-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lenzumestrocel | Cell therapy | 1e+06 cells/kg | Intrathecal |
| Background | Riluzole | Small molecule | — | — |